ATE376066T1 - Verfahren zur abschätzung der sensitivität für osteoporose-medikamente - Google Patents

Verfahren zur abschätzung der sensitivität für osteoporose-medikamente

Info

Publication number
ATE376066T1
ATE376066T1 AT00110219T AT00110219T ATE376066T1 AT E376066 T1 ATE376066 T1 AT E376066T1 AT 00110219 T AT00110219 T AT 00110219T AT 00110219 T AT00110219 T AT 00110219T AT E376066 T1 ATE376066 T1 AT E376066T1
Authority
AT
Austria
Prior art keywords
genetic polymorphisms
osteoporosis
receptor gene
gene
medicine
Prior art date
Application number
AT00110219T
Other languages
English (en)
Inventor
Masataka Shiraki
Yasuyoshi Ouchi
Takayuki Hosoi
Nobutaka Kusaba
Toshiaki Baba
Hiroshi Yoshida
Original Assignee
Nipro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP16564299A external-priority patent/JP3684921B2/ja
Application filed by Nipro Corp filed Critical Nipro Corp
Application granted granted Critical
Publication of ATE376066T1 publication Critical patent/ATE376066T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00110219T 1999-05-18 2000-05-18 Verfahren zur abschätzung der sensitivität für osteoporose-medikamente ATE376066T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13665399 1999-05-18
JP16564299A JP3684921B2 (ja) 1999-06-11 1999-06-11 骨粗鬆症薬剤感受性予測方法

Publications (1)

Publication Number Publication Date
ATE376066T1 true ATE376066T1 (de) 2007-11-15

Family

ID=26470156

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00110219T ATE376066T1 (de) 1999-05-18 2000-05-18 Verfahren zur abschätzung der sensitivität für osteoporose-medikamente

Country Status (4)

Country Link
US (1) US6566064B1 (de)
EP (1) EP1054066B1 (de)
AT (1) ATE376066T1 (de)
DE (1) DE60036750T2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005500246A (ja) * 2001-12-03 2005-01-06 マギル ユニヴァーシティー メチレンテトラヒドロ葉酸還元酵素阻害剤およびそれらの使用
KR100459493B1 (ko) * 2002-01-31 2004-12-03 김기수 골다공증의 발생 위험을 예측하는 방법 및 이를 이용한골다공증의 유전적 위험 인자에 대한 진단 키트
US8688385B2 (en) 2003-02-20 2014-04-01 Mayo Foundation For Medical Education And Research Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype
EP1749017A2 (de) * 2004-05-27 2007-02-07 MIGENIX Corp. Verbindungen und verfahren für zytoprotektion
WO2006091092A1 (en) * 2005-02-28 2006-08-31 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Polymorphism analysis of the estrogen receptor and vitamin d receptor to predict therapy responsiveness in the treatment of osteoporosis
ES2529211T3 (es) * 2005-11-29 2015-02-18 Children's Hospital Medical Center Optimización e individualización de la selección y dosificación de medicamentos
GB0614620D0 (en) * 2006-07-24 2006-08-30 Genomica Sau Assay for diagnosing a predisposition to pathological bone conditions and anticipating response to treatment
CN102596190A (zh) 2009-09-14 2012-07-18 雀巢产品技术援助有限公司 包含外源性维生素k2的营养组合物
US10445846B2 (en) 2011-04-14 2019-10-15 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
US10853819B2 (en) 2011-04-14 2020-12-01 Elwha Llc Cost-effective resource apportionment technologies suitable for facilitating therapies
CN108451929B (zh) * 2017-02-21 2021-04-16 上海交通大学医学院 一种包载固相内核的重组脂蛋白及其制备和应用

Also Published As

Publication number Publication date
US6566064B1 (en) 2003-05-20
EP1054066A3 (de) 2004-02-25
EP1054066A2 (de) 2000-11-22
DE60036750T2 (de) 2008-08-28
EP1054066B1 (de) 2007-10-17
DE60036750D1 (de) 2007-11-29

Similar Documents

Publication Publication Date Title
Shearer et al. Deafness in the genomics era
CN105112502B (zh) 用于检测与糖尿病相关的snp位点组合的成套引物及其应用
CN107190064B (zh) 检测22个位点耳聋基因多态性的SNaPshot试剂盒
ATE376066T1 (de) Verfahren zur abschätzung der sensitivität für osteoporose-medikamente
US20030143572A1 (en) Molecular diagnostic and computerized decision support system for selecting the optimum treatment for human cancer
CN106319040A (zh) 一种检测人cyp2c19基因分型的试剂盒及检测方法
JP5216982B2 (ja) 禁煙支援治療に有用な遺伝子多型
CN108048565A (zh) 一种检测ApoE基因多态性的引物及其检测方法和应用
CN101861523A (zh) 传染病的自动检测
KR101712463B1 (ko) 혈압강하제 및 동맥 경화용제 대사효소 관련 유전자 snp 지노타이핑 시약, 이를 포함하는 키트 및 유전자형 분석방법
CN110656112B (zh) 一种Liddle综合征基因检测试剂盒
DE60014887D1 (de) Analyseverfahren zur feststellung der prädisposition enes patienten auf mindestens eine erkrankung sowie geeignete amplifizierung für ein solches verfahren
JP6596724B1 (ja) 白髪の遺伝的素因の判定方法
CN105274197B (zh) 用于生物样本核酸检测的质控方法及试剂盒
Chiou et al. Detection of common sequence variations of familial hypercholesterolemia in Taiwan using DNA mass spectrometry
CN105838720A (zh) Ptprq基因突变体及其应用
Jung et al. Development of HLA-B* 57: 01 genotyping real-time PCR with optimized hydrolysis probe design
CN114729395A (zh) 检查脑肿瘤的方法
RU2607031C1 (ru) Способ выявления кандидатных генов для проведения популяционных исследований генетического полиморфизма у детей, проживающих в условиях стронциевой геохимической провинции
CN107828889B (zh) 一种用于hla-drb1*03基因定性检测的pcr扩增引物及试剂盒
RU2006101561A (ru) Способы обнаружения болезни альцгеймера
KR101712460B1 (ko) 항바이러스제 대사효소와 수용체 관련 유전자 snp 지노타이핑 시약, 이를 포함하는 키트 및 유전자형 분석방법
JP5396009B2 (ja) 骨粗鬆症感受性遺伝子、及び骨粗鬆症罹患リスクの測定方法
KR100790226B1 (ko) 독성 간염 유발 감수성을 검출하는 방법
Wang et al. High throughput analysis of tandem repeat contraction associated with Facioscapulohumeral Muscular Dystrophy (FSHD) by optical mapping

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties